Pharmaxis Limited - Australian Company Profile

What does Pharmaxis Limited do?

Pharmaxis is a Public Company that generates the majority of its income from the Scientific Research Services industry.

In 2024 the company generated total revenue of $6,210,000 including sales and other revenue. The exact number of employees for this organisation is not available.

The Chief Executive of Pharmaxis is Mr Gary Phillips whose official title is Managing Director. The Chairman of Pharmaxis is Mr Malcolm McComas whose official title is Independent Chairman.

Pharmaxis Limited is an ASX-listed company that is a drug developer for combatting inflammatory and fibrotic diseases in the pharmaceuticals industry. The Company develops two main drug products: Bronchitol (the treatment for cystic fibrosis, approved and marketed in Europe, Russia, Australia and the United States of America) Aridol (a bronchial challenge test for the diagnosis and examination of asthma, approved and marketed in the United States of America, Europe, Australia, Canada and Asia)

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Pharmaxis Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Pharmaxis Limited by position type and title.

Enterprise Financials

Get a full view of Pharmaxis Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Pharmaxis Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Pharmaxis Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Pharmaxis Limited operates in.

Competitor Benchmarking

Compare Pharmaxis Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Pharmaxis Limited.

Subsidiaries

View a list of Pharmaxis Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Pharmaxis Limited, including founding information, past announcements, mergers and major projects.